Lion Point Capital, LP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001643354

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltBuy & Hold how tags are computed

Q3 2026 · 34 positions · Total reported value $17.26M · Top-10 concentration 56.1% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 2.9% · 0 new · 0 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -15.0% · vs SPY -17.1% · Prev Value $20.91M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.4% · vs SPY -5.5% · Latest Value $17.26M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Lion Point Capital, LP disclosed 34 equity positions with a combined reported value of $17.26M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 56.1% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / Buy & Hold.

The largest disclosed positions as of Q3 2026 were CUE ($1.37M), PRAX ($1.30M), RPRX ($1.25M). By sector, the heaviest allocations are Health Care 98.0%, Technology 2.0%. Versus the prior quarter, allocation shifted toward Technology (+0.8pp) and away from Health Care (-0.8pp).

Versus the prior quarter, Lion Point Capital, LP opened 0 new positions, trimmed 0 and fully exited 1, a turnover rate of 2.9% of positions. The portfolio's overlap with the prior quarter was 97% of names.

Of the 1 positions fully exited versus the prior quarter, the largest were LNTH ($610.17K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

No new positions this quarter.

Fully Exited (vs previous quarter)

  • LNTH LANTHEUS HLDGS INC · prev qtr: $610.17K

Insider Transactions (Form 4)

Latest Lion Point Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Lion Point Capital, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 35 US equity positions with a combined value of $20.91M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-81004 (status: Approved), registered 2015-02-25
  • Regulatory AUM (Form ADV): $480.60M as of 2026-04-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 2 hedge funds
  • Website: lionpoint.com

Portfolio Structure

  • 35 positions · $20.91M reported value (Q2 2026)
  • Top 10 holdings = 55.0% of reported value
  • Largest position: CUE (Cue Biopharma Inc) at 8.0%
  • Average position size: $597.29K

Sector Tilt

  • Health Care 98.8%
  • Information Technology 1.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 reduced
  • 34 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 98.0%
Technology 2.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 52.93K $1.37M 7.93%
7.93%
Hold
2 4.45K $1.30M 7.51%
7.51%
Hold
3 21.40K $1.25M 7.24%
7.24%
Hold
4 112.43K $1.20M 6.94%
6.94%
Hold
5 80.00K $995.20K 5.77%
5.77%
Hold
6 67.50K $789.75K 4.58%
4.58%
Hold
7 578.00K $710.94K 4.12%
4.12%
Hold
8 820.00K $709.87K 4.11%
4.11%
Hold
9 51.70K $690.20K 4.00%
4.00%
Hold
10 36.00K $676.80K 3.92%
3.92%
Hold
11 62.00K $620.00K 3.59%
3.59%
Hold
12 8.10K $530.23K 3.07%
3.07%
Hold
13 28.50K $519.27K 3.01%
3.01%
Hold
14 46.00K $492.66K 2.85%
2.85%
Hold
15 27.70K $490.84K 2.84%
2.84%
Hold
16 128.65K $439.98K 2.55%
2.55%
Hold
17 9.10K $369.46K 2.14%
2.14%
Hold
18 14.70K $355.15K 2.06%
2.06%
Hold
19 9.70K $338.43K 1.96%
1.96%
Hold
20 13.50K $338.18K 1.96%
1.96%
Hold
21 650.00K $336.50K 1.95%
1.95%
Hold
22 5.00K $329.00K 1.91%
1.91%
Hold
23 19.00K $328.32K 1.90%
1.90%
Hold
24 18.00K $289.98K 1.68%
1.68%
Hold
25 465.00K $269.70K 1.56%
1.56%
Hold
26 10.50K $263.87K 1.53%
1.53%
Hold
27 10.20K $239.50K 1.39%
1.39%
Hold
28 86.00K $226.18K 1.31%
1.31%
Hold
29 26.60K $200.30K 1.16%
1.16%
Hold
30 8.20K $173.92K 1.01%
1.01%
Hold
31 5.25K $138.76K 0.80%
0.80%
Hold
32 81.15K $132.28K 0.77%
0.77%
Hold
33 31.57K $105.76K 0.61%
0.61%
Hold
34 1.00K $48.58K 0.28%
0.28%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 70% R 70% F1 70% (modelled on 2026-Q1; 7/10 hit)

Low-confidence forecast This fund replaces about 23% of its Top-10 each quarter and backtests at F1 78% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 78% · recall 78% · F1 78% · avg rank error 2.8 · Top-10 turnover 23%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 70% 70% 70% SMTC · IWM · MRNS · ARDX · MIST · HARP · BFICQ · KNSA · INSM · CBAY IWM · MRNS · ARDX · XBI · MIST · KNSA · GERN · INSM · FENC · BFICQ
2024-Q2 90% 90% 90% IWM · MRNS · ARDX · XBI · MIST · KNSA · FENC · GERN · INSM · SNDX IWM · ARDX · INSM · XBI · MIST · GERN · MRNS · KNSA · MIRM · SNDX
2024-Q3 80% 80% 80% IWM · ARDX · INSM · XBI · MIST · GERN · MRNS · KNSA · MIRM · SNDX IWM · INSM · GERN · ARDX · MIST · BHVN · MIRM · KNSA · BBIO · MRNS
2024-Q4 70% 70% 70% IWM · INSM · GERN · MIST · ARDX · BHVN · MIRM · KNSA · BBIO · MRNS INSM · MIST · GERN · ARDX · FENC · BBIO · MLYS · KNSA · BHVN · BNTC
2025-Q1 80% 80% 80% INSM · MIST · GERN · ARDX · FENC · BBIO · MLYS · BNTC · KNSA · BHVN INSM · ARDX · MLYS · FENC · KNSA · BBIO · BNTC · GERN · AVDL · ARQT
2025-Q2 80% 80% 80% INSM · ARDX · MLYS · FENC · KNSA · BNTC · BBIO · AVDL · GERN · ARQT FENC · ARDX · KNSA · BBIO · INSM · MLYS · MIST · AVDL · JSPR · BNTC
2025-Q3 90% 90% 90% FENC · ARDX · KNSA · BBIO · MLYS · MIST · INSM · AVDL · JSPR · BNTC MLYS · MIST · FENC · JSPR · AVDL · KNSA · INSM · ARDX · BNTC · SNDX
2025-Q4 60% 60% 60% MLYS · MIST · FENC · JSPR · AVDL · BNTC · KNSA · SNDX · ARDX · INSM MIST · PRAX · MLTX · FENC · JSPR · BNTC · RPRX · GERN · SNDX · ARDX
2026-Q1 90% 90% 90% MIST · PRAX · JSPR · MLTX · BNTC · RPRX · FENC · GERN · SNDX · ARDX PRAX · MLTX · RPRX · MIST · GERN · SNDX · ARDX · FENC · BNTC · SRPT
2026-Q2 ★ 70% 70% 70% PRAX · MLTX · RPRX · MIST · GERN · SNDX · ARDX · FENC · BNTC · SRPT CUE · PRAX · MLTX · FENC · RPRX · CMPS · MIST · BNTC · SNDX · BHVN

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings1 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return+17.57%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+34.58%vs benchmark
Barra annualised vol54.9%Model estimate
Realised vol33.0%Annualised in window
Weighted beta1.12Raw exposure
Factor / specific risk27% / 73%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)77.088.8100.6112.3124.110-0110-2311-16Lion Point Capital, LPQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+17.57%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+34.58%Portfolio − benchmark
Arithmetic return sum+16.91%Difference vs compounded is the cross term
Weighted raw beta1.12Weighted holding betas
Realised volatility (annualised)32.95%Daily returns in window
Barra model volatility (annualised)54.89%Factor + specific
Factor share of variance26.7%Barra factors
Specific share of variance73.3%Stock residuals
Reported value$329,00013F long US equity

2. Return attribution

The +16.91% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +2.43% 14.4%
Momentum & Growth 3 -3.58% -21.2%
Volatility & Tail Risk 7 +6.00% 35.5%
Industry 12 +6.98% 41.3%
Specific 1 +5.06% 29.9%
Return attribution (style + industry, %)-17.4-8.7+0.0+8.7+17.4Amihud Illiquidity-0.59Max Drawdown-0.76Mid Cap-0.94Beta+1.19Short-term Reversal+1.21Non-linear Size+1.24Residual Volatility+2.15Momentum-2.18Size+2.41Growth-2.61Historical Volatility-3.64Health Care+6.98Skewness-9.58Kurtosis+16.08
Factor Type Exposure Factor return Contribution Share of |return|
Kurtosis Style +2.14 +7.51% +16.08% 95.1%
Health Care Industry +1.00 +6.98% +6.98% 41.3%
Specific Specific — — +5.06% 29.9%
Size Style -1.24 -1.95% +2.41% 14.2%
Residual Volatility Style +0.65 +3.29% +2.15% 12.7%
Non-linear Size Style +1.23 +1.01% +1.24% 7.3%
Short-term Reversal Style +1.39 +0.87% +1.21% 7.2%
Beta Style +0.27 +4.44% +1.19% 7.0%
Leverage (Downside Vol) Style -0.33 -1.71% +0.57% 3.4%
Turnover Style -0.10 -4.80% +0.47% 2.8%
Liquidity Style -0.45 +0.36% -0.16% -0.9%
Amihud Illiquidity Style +1.32 -0.45% -0.59% -3.5%
Max Drawdown Style +0.43 -1.76% -0.76% -4.5%
Mid Cap Style +0.48 -1.94% -0.94% -5.5%
Momentum Style +0.55 -4.00% -2.18% -12.9%
Growth Style -1.49 +1.75% -2.61% -15.4%
Historical Volatility Style +0.26 -14.00% -3.64% -21.5%
Skewness Style +2.18 -4.39% -9.58% -56.6%

3. Risk attribution

Annualised volatility is 54.89%; factor risk explains 26.7% of variance and specific risk 73.3%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-79.1-39.6+0.0+39.6+79.1Residual Volatility-0.66Short-term Reversal-0.62Leverage (Downside Vol)-0.62Non-linear Size-0.61Max Drawdown-0.61Amihud Illiquidity+0.61Beta+0.63Momentum+0.98Kurtosis+2.11Size+2.63Growth+4.32Skewness+7.60Health Care+10.61Specific+73.26
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 73.3% +40.21% 40.2%
Health Care Industry +1.00 10.6% +5.82% 5.8%
Skewness Style +2.18 7.6% +4.17% 4.2%
Growth Style -1.49 4.3% +2.37% 2.4%
Size Style -1.24 2.6% +1.44% 1.4%
Kurtosis Style +2.14 2.1% +1.16% 1.2%
Momentum Style +0.55 1.0% +0.54% 0.5%
Beta Style +0.27 0.6% +0.35% 0.3%
Amihud Illiquidity Style +1.32 0.6% +0.34% 0.3%
Liquidity Style -0.45 0.4% +0.21% 0.2%
Mid Cap Style +0.48 0.2% +0.13% 0.1%
Historical Volatility Style +0.26 -0.2% -0.12% -0.1%
Non-linear Size Style +1.23 -0.6% -0.34% -0.3%
Max Drawdown Style +0.43 -0.6% -0.33% -0.3%
Short-term Reversal Style +1.39 -0.6% -0.34% -0.3%
Leverage (Downside Vol) Style -0.33 -0.6% -0.34% -0.3%
Residual Volatility Style +0.65 -0.7% -0.36% -0.4%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.9-0.80.31.42.5Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -1.24 +2.10 -3.33
Non-linear Size +1.23 +1.68 -0.45
Mid Cap +0.48 +0.13 +0.36
Beta +0.27 +1.29 -1.03
Momentum +0.55 +0.72 -0.17
Short-term Reversal +1.39 -0.64 +2.03
Residual Volatility +0.65 -0.40 +1.05
Historical Volatility +0.26 +0.86 -0.60
Liquidity -0.45 +0.11 -0.56
Amihud Illiquidity +1.32 +1.16 +0.16
Turnover -0.10 +0.21 -0.30
Growth -1.50 +0.58 -2.08
Leverage (Downside Vol) -0.33 +0.14 -0.47
Skewness +2.18 +0.24 +1.94
Kurtosis +2.14 +0.21 +1.93
Max Drawdown +0.43 -0.08 +0.52

5. Industry allocation & Brinson

Industry allocation (weight, %)-10.020.050.080.0110.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Health Care 100.0% 1.7% +17.57% +8.29% +24.98% +0.16% +9.12% +17.43%
Information Technology 0.0% 73.6% +0.00% -22.33% +3.83% +16.44% -16.44% +16.44%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.26% -0.27% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +3.76% -1.84% -0.33% +0.33% -0.33%
Industrials 0.0% 11.1% +0.00% +4.36% -2.39% -0.48% +0.48% -0.48%
Total +23.98% +16.00% -6.72% +33.27%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
BBIO BRIDGEBIO PHARMA INC Health Care 100.00% +17.57% +17.57% Hold
Contribution rank Symbol Sector Weight Return Contribution
1 BBIO Health Care 100.00% +17.57% +17.57%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned +17.57%, versus -17.01% for the QQQ synthetic benchmark — an excess of +34.58%.
  2. Return attribution: the largest positive style/industry contributions came from Kurtosis +16.08%, Health Care +6.98%, Size +2.41%; the largest drags came from Skewness -9.58%, Historical Volatility -3.64%, Growth -2.61%. Specific (stock-level) return contributed +5.06%.
  3. Risk attribution: Barra model volatility is 54.89% annualised; factor risk explains 27% of variance and specific risk 73%. The largest factor risk sources are Health Care 10.6%, Skewness 7.6%, Growth 4.3%.
  4. Style tilt: size -1.24, momentum +0.55, volatility +0.26, liquidity -0.45; the weighted raw beta is 1.12. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+98.3 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +23.98%, selection +16.00% and interaction -6.72%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Lion Point Capital, LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Lion Point Capital, LP reported 34 equity positions worth $17.26M in aggregate; its largest disclosed positions were CUE ($1.37M), PRAX ($1.30M), RPRX ($1.25M).

How large is Lion Point Capital, LP's portfolio?

Lion Point Capital, LP reported $17.26M of long equity holdings across 34 positions as of 2026-Q3. Top-10 holdings account for 56.1% of reported value.

What is Lion Point Capital, LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/lion-point-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →